文章的最高境界-让人无法重复出来?

看到2020年2月发表在nature cancer这个新杂志的文章《Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer》链接是:https://www.nature.com/articles/s43018-019-0020-z 里面有普通的18个样品的bulk转录组数据以及25个单细胞转录组数据。

image-20201030101015693
主要是 (CTC)-derived xenografts (CDXs) ,听说过是技术难度很高!

首先是突变全景图很突兀,也很诡异

如下:
突变全景图
全文反正也没有提到如何测序,是WGS,WES还是说仅仅是 panel,没有突变数据分析的描述,仅仅是提到了BWA和VARSCAN软件而已,也不上传数据。这样的话,我们只能是假设研究者没有造假咯!
反正没有数据可以下载,而且作者描述的也超级简陋,做啥图表复现都不可能额!

单细胞呢,好像缺一个样品!!

单细胞的实验环节,正文里面说的倒是很清楚,是目前主流的10X商业化仪器的数据 :
Sorted cells were washed once with 0.04% bovine serum albumin in phosphate-buffered saline and counted on a Countess II automated cell counter (Thermo Fisher Scientific). A total of 12,200 cells were loaded per lane on the 10× Chromium platform and processed for complementary DNA synthesis and library preparation, per the manufacturer’s protocol using version 2 chemistry. Complementary DNA and libraries were checked for quality on an Agilent 4200 TapeStation and quantified by KAPA quantitative PCR before sequencing on a single lane of a HiSeq 4000 (Illumina).
数据分析细节如下:
单细胞数据分析细节
完全没办法接受研究者的阈值,居然是表达的基因数量少于3000的细胞直接就过滤了!!!这个是10X商业化仪器的数据 啊~~~
而且明明是8个单细胞转录组的 CDXs 数据 ,正文也写了; t-SNE analysis of eight CDXs. 结论是: Cells from each CDX were more similar to themselves than to other models. 但是上传的数据呢,缺失那个 HCI开头的样品:

Comments are closed.